Perioperative radiotherapy and concurrent radiochemotherapy in rectal cancer

Seminars in Surgical Oncology

Volumn 20, Issue 1, 2001, Pages 3-12

  Rödel, Claus ^a,b   Sauer, Rolf ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Adjuvant; Chemotherapy; Colorectal neoplasms; Colorectal surgery; Combined modality therapy; Radiotherapy; Survival

Indexed keywords

FLUOROURACIL; IRINOTECAN; MITOMYCIN; OXALIPLATIN;

ADVANCED CANCER; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; HUMAN; MULTIMODALITY CANCER THERAPY; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RECTUM CANCER; REVIEW;

CHEMOTHERAPY, ADJUVANT; HUMANS; PERIOPERATIVE CARE; RECTAL NEOPLASMS;

EID: 0035053812     PISSN: 87560437     EISSN: None     Source Type: Journal    
DOI: 10.1002/ssu.1011     Document Type: Review

References (64)

1. NIH Consensus Conference: Adjuvant therapy for patients with colon and rectal cancer
2. Adjuvante therapie bei kolon- und rektumkarzinom
3. Mesorectal excision for rectal cancer
4. Total mesorectal excision - The new golden standard of surgery for rectal cancer
5. Influence of surgery on metachronous distant metastases and survival in rectal cancer
6. Prognostic factors in stage T3N0 rectal cancer. Do all patients require postoperative pelvic irradiation and chemotherapy?
7. Prognostic factors of rectum carcinoma
8. The effect of specialization or organization in rectal cancer surgery
9. Survival after postoperative combination treatment of rectal cancer
10. Effective surgical adjuvant therapy for high-risk rectal carcinoma
11. Randomized controlled trial of postoperative radiotherapy and short-term time-scheduled 5-fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer
12. Radiation therapy and fluorouracil with or without semustine for the treatment of patients with surgical adjuvant adenocarcinoma of the rectum
13. Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery
14. Total mesorectal excision (TME) with or without preoperative radiotherapy in the treatment of primary rectal cancer. Prospective randomised trial with standard operative and histopathological techniques
15. Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02
16. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: Results from NSABP Protocol R-01
17. The long-term effect of adjuvant postoperative chemoradiotherapy for rectal carcinoma on bowel function
18. Morbidities of adjuvant chemotherapy and radiotherapy for resectable rectal cancer. An overview
19. Dose-response relationship for radiation therapy of subclinical disease
20. Adjuvant postoperative fluorouracil-modulated chemotherapy combined with pelvic radiation therapy for rectal cancer: Initial results of Intergroup 0114
21. Acceptance and toxicity of postoperative adjuvant therapy in colon and rectal cancer
22. A randomized phase III trial comparing irinotecan + 5-FU/folinic acid to the same schedule of 5-FU/folinic acid in patients with metastatic colorectal cancer as front line therapy
23. Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer
24. Akuttoxizität der simultanen radiochemotherapie des rektumkarzinoms
25. Combined modality therapy of rectal cancer: Decreased acute toxicity with the preoperative approach
26. Neoadjuvant and adjuvant radio- and radio-chemotherapy of rectal carcinomas
27. Improved survival with preoperative radiotherapy in resectable rectal cancer
28. Adjuvant therapy for rectal cancer - A good first step
29. Adjuvante und neoadjuvante therapie des rektumkarzinoms
30. Influence of the interval between preoperative radiation therapy and surgery on downstaging and the rate of sphincter-sparing surgery for rectal cancer: The Lyon R90-01 randomized trial
31. Acute lumbosacral plexopathy after preoperative radiotherapy in rectal carcinoma
32. Prospectively randomized trial of preoperative versus postoperative radiochemotherapy for advanced rectal cancer - First results regarding surgical morbidity and toxicity of (neo-)adjuvant treatment
33. Preoperative irradiation affects functional results after surgery for rectal cancer
34. Preoperative concurrent 5-fluorouracil infusion, mitomycin C and pelvic radiation therapy in tethered and fixed rectal carcinoma
35. The efficacy of preoperative 5-fluorouracil, high-dose leucovorin, and sequential radiation therapy for unresectable rectal cancer
36. Preoperative treatment of patients with locally advanced unresectable rectal adenocarcinoma utilizing continuous chronobiologically shaped 5-fluorouracil infusion and radiation therapy
37. Preoperative radiation with concurrent 5-fluorouracil continuous infusion for locally advanced unresectable rectal cancer
38. Preoperative radiation with concurrent 5-fluorouracil for locally advanced T4-primary rectal cancer
39. Enhancement of radiation induced downstaging of rectal cancer by fluorouracil and high-dose leucovorin chemotherapy
40. Preoperative radio-chemothermo-therapy in locally advanced rectal cancer
41. Preoperative radiation therapy followed by local excision
42. Neoadjuvant chemoradiotherapy with sphincter-sparing surgery for low lying rectal cancer
43. Sphincter preservation with preoperative radiation therapy and coloanal anastomosis: Long term follow-up
44. Preliminary results of preoperative 5-fluorouracil (5-FU), low dose leucovorin, and concurrent radiation therapy for resectable T3 rectal cancer
45. Conservative surgery for low rectal carcinoma after high-dose radiation
46. A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum: A progress report of NSABP R-03
47. Adjuvant therapy of rectal cancer
48. Pre- or postoperative radiotherapy in rectal and rectosigmoid carcinoma
49. Incompletely resected rectum, rectosigmoid, or sigmoid carcinoma: Results of postoperative radiotherapy and prognostic factors
50. Results and complications of surgery combined with intraoperative radiation therapy for the treatment of locally advanced or recurrent cancers in the pelvis
51. High dose rate intraoperative radiation therapy (HDR-IORT) as part of the management strategy for locally advanced primary and recurrent rectal cancer
52. Indications for and results of combined modality treatment of colorectal cancer
53. Locally advanced primary colorectal cancer: Intraoperative electron and external beam irradiation +/- 5-FU
54. Intraoperative electron and external beam irradiation with or without 5-fluorouracil and maximum surgical resection for previously unirradiated, locally recurrent colorectal cancer
55. Aggressive multimodality treatment for locally advanced irresectable rectal cancer
56. High-dose-rate intraoperative brachytherapy for recurrent colorectal cancer
57. Intraoperative electron beam radiation therapy for locally recurrent rectal carcinoma
58. Feasibility and first results of multimodality treatment, combining EBRT, extensive surgery, and IORT in locally advanced primary rectal cancer
59. Moderate dose intraoperative and external beam radiotherapy for locally recurrent rectal carcinoma
60. Is radiochemotherapy necessary in the treatment of rectal cancer?
61. Current controversies in cancer. Is there a standard adjuvant treatment for rectal cancer?
62. Technical advances in the treatment of patients with rectal cancer